Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Data solutionsForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Index solutionsForge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Forge Thematic BasketsExplore focused views into key private market themesLiquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarEmerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Data solutions
Index solutions
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Trade private companies

Browse IPO companies

View private companies that have successfully transitioned to the public markets after completing an initial public offering (IPO). 

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Post-Money Valuation
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Filters (2)
More (2)
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Post-Money Valuation
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Reset
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
Aardvark TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$129.13MSeries C5/9/2024$85M$267.58M$1.77Decheng Capital, Cormorant Asset Management, Surveyor Capital, SymBiosis, Tetragon Financial Group, Walleye Capital, Laurion Capital Management, LG Technology Ventures, Cantor Ventures, Silver Arc Private Capital, Prader-Willi Syndrome Association, Vickers Venture Partners, Foundation for Prader-Willi Research
Brii BioSciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Revolution MedicinesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Alto NeuroscienceHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$253.17MSeries C11/21/2023$50.31M$235.65M$4.71InVivium Capital, Franklin Templeton, Point72, Eli Lilly and Company, Alexandria Venture Investments, Alpha Wave Ventures, Lightswitch Capital, Alkeon Capital, WhatIf Ventures, Windham Venture Partners
Annexon BiosciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
CAMP4Healthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$113.77MSeries B7/20/2022$100.54M$297.52M$1.47Patient Square Capital, Gaingels, 5AM Ventures, Polaris Partners, Northpond Ventures, Andreessen Horowitz, The Kraft Group
Contineum TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$133.61MSeries C2/11/2021$80.4M$244.63M$2.68Perceptive Advisors, Franklin Templeton, Casdin Capital, Samsara BioCapital, Suvretta Capital, Red Tree Venture Capital, Versant Ventures, Sectoral Asset Management, Cleva Pharma
EvommuneHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$268.46MSeries C10/31/2024$115.5M$346.35M$1.59RA Capital Management, Sectoral Asset Management, B Capital, Marshall Wace, Avego Bioscience Capital, Longwood Fund, RTW Investments, ADAR1 Capital Management, NEXTBio Capital, Beiersdorf Venture Capital, FemHealth Ventures, Allostery Investments LP, Pivotal bioVenture Partners, EQT Life Sciences, Andera Partners, Amplitude Ventures, SymBiosis, Verition Fund Management
IsoPlexisHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$161.52MSeries D1/7/2021$92.5M$348.21M$76.92Perceptive Advisors, Ally Bridge Group, BlackRock
MineralysHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$159.18MSeries B6/8/2022$118M$267.43M$0.86RA Capital Management, Andera Partners, RTW Investments, Rock Springs Capital, SR One Capital Management, Sectoral Asset Management, Ysis Capital, HealthCor Management, Boulder Ventures, Catalys Pacific, Samsara BioCapital, HBM Healthcare Investments, Adams Street Partners
Zenas BioPharmaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
ArriVent BiopharmaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$260MSeries B12/16/2022$110M$375.08M$1.05Undisclosed Investors
NeumoraHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$612.4MSeries B10/11/2022$112.4M$1.33B$1.50Abu Dhabi Growth Fund, Altitude Life Science Ventures, Amgen, ARCH Venture Partners, Exor Ventures, F-Prime Capital, Invus, Mubadala Capital, Newpath Partners, Polaris Partners
Passage BioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Bolt BiotherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Boundless BioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$756.15MSeries C5/16/2023$100M$273.76M$0.70Bayer, RA Capital Management, Sectoral Asset Management, Piper Heartland, Healthcare Capital
Edgewise TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Inozyme PharmaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Kronos BioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
PMV PharmaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Seaport TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$330.1MSeries B10/21/2024$226M$725.46M$14.92General Atlantic, T. Rowe Price Associates, Foresite Capital, Invus, Goldman Sachs, CPP Investments, ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, PureTech Health
XtalPiHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
10x Genomics, Inc.Healthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$222.59MSeries D-11/7/2019$35M$1.34B$12.73Meritech Capital, Fidelity, Wells Fargo
AlumisHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.66BSeries C3/6/2024$259M$702.67M$3.14Foresite Capital, Samsara BioCapital, venBio Partners, Cormorant Asset Management, SR One, Lilly Asia Ventures, Nextech, Ally Bridge Group, HBM Healthcare Investments, Omega Funds, Piper Heartland Healthcare, AyurMaya Capital Management
25-48 of 86

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.